These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Loss of porin function in dopaminergic neurons of Drosophila is suppressed by Buffy. M'Angale PG; Staveley BE J Biomed Sci; 2016 Nov; 23(1):84. PubMed ID: 27881168 [TBL] [Abstract][Full Text] [Related]
3. A loss of Pdxk model of Parkinson disease in Drosophila can be suppressed by Buffy. M'Angale PG; Staveley BE BMC Res Notes; 2017 Jun; 10(1):205. PubMed ID: 28606139 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of the putative Lifeguard homologue CG3814 in neurons of Drosophila melanogaster. M'Angale PG; Staveley BE Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002605 [TBL] [Abstract][Full Text] [Related]
6. The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila. M'Angale PG; Staveley BE BMC Neurosci; 2016 May; 17(1):24. PubMed ID: 27192974 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Buffy enhances the loss of parkin and suppresses the loss of Pink1 phenotypes in Drosophila. M'Angale PG; Staveley BE Genome; 2017 Mar; 60(3):241-247. PubMed ID: 28106473 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Atg6 and Pi3K59F autophagy genes in neurons decreases lifespan and locomotor ability in Drosophila melanogaster. M'Angale PG; Staveley BE Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27813607 [TBL] [Abstract][Full Text] [Related]
9. The HtrA2 Drosophila model of Parkinson's disease is suppressed by the pro-survival Bcl-2 Buffy. M'Angale PG; Staveley BE Genome; 2017 Jan; 60(1):1-7. PubMed ID: 27848260 [TBL] [Abstract][Full Text] [Related]
10. Hasan A; Staveley BE Biomolecules; 2024 Aug; 14(9):. PubMed ID: 39334855 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of mitochondrial calcium uptake 1 in Drosophila neurons. M'Angale PG; Staveley BE Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28198506 [TBL] [Abstract][Full Text] [Related]
12. spargel, the PGC-1α homologue, in models of Parkinson disease in Drosophila melanogaster. Merzetti EM; Staveley BE BMC Neurosci; 2015 Oct; 16():70. PubMed ID: 26502946 [TBL] [Abstract][Full Text] [Related]
13. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease. Haywood AF; Staveley BE BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075 [TBL] [Abstract][Full Text] [Related]
14. Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease. Todd AM; Staveley BE Genome; 2008 Dec; 51(12):1040-6. PubMed ID: 19088817 [TBL] [Abstract][Full Text] [Related]
15. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease. Lee S; Bang SM; Hong YK; Lee JH; Jeong H; Park SH; Liu QF; Lee IS; Cho KS Dis Model Mech; 2016 Mar; 9(3):295-306. PubMed ID: 26659252 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitor captopril prevents neuronal overexpression of amyloid-beta and alpha-synuclein in Drosophila melanogaster genetic models of neurodegenerative diseases. Ishola I; Afolayan O; Badru A; Olubodun-Obadun T; John N; Adeyemi O Niger J Physiol Sci; 2022 Jun; 37(1):21-28. PubMed ID: 35947848 [TBL] [Abstract][Full Text] [Related]
17. Mutant alpha-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease. Haywood AF; Staveley BE Genome; 2006 May; 49(5):505-10. PubMed ID: 16767175 [TBL] [Abstract][Full Text] [Related]
18. Expression of Pink1 with α-synuclein in the dopaminergic neurons of Drosophila leads to increases in both lifespan and healthspan. Todd AM; Staveley BE Genet Mol Res; 2012 May; 11(2):1497-502. PubMed ID: 22653599 [TBL] [Abstract][Full Text] [Related]
19. Ashwagandha- Withania somnifera (L.) Dunal as a multipotent neuroprotective remedy for genetically induced motor dysfunction and cellular toxicity in human neurodegenerative disease models of Drosophila. Murthy MN; Shyamala BV J Ethnopharmacol; 2024 Jan; 318(Pt A):116897. PubMed ID: 37442493 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of hesperidin in Parkinson's disease with dementia: inhibition of alpha synuclein and amyloid beta in Drosophila melanogaster. Ishola IO; Afolayan O; O Odutola I; Faniyan O; O Adeyemi O Niger J Physiol Sci; 2021 Jun; 36(1):43-48. PubMed ID: 34987244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]